Drug Type Small molecule drug |
Synonyms AES 135, AES135 |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H29F6N3O5S |
InChIKeyLTRKEOBJRDKIHB-UHFFFAOYSA-N |
CAS Registry2361659-61-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CA | 06 Mar 2019 |